| Name | Kroger Pharmacy #672 |
|---|---|
| Organization Name | Kroger Limited Partnership I |
| Location | 45 Plaza Dr, Anna, Illinois 62906 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (618) 833-4521 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
The first non-prescription diet drug ever to be approved by the FDA hit the shops this week and optimistic dieters are dashing out to buy it.
In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."
Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease.
Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.
› Verified 2 days ago
| NPI Number | 1407880214 |
| Organization Name | KROGER LIMITED PARTNERSHIP I |
| Doing Business As | KROGER PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 45 Plaza Dr, Anna, IL 62906 |
| Phone Number | 618-833-4521 |
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
The first non-prescription diet drug ever to be approved by the FDA hit the shops this week and optimistic dieters are dashing out to buy it.
In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."
Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease.
Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.
› Verified 2 days ago
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
The first non-prescription diet drug ever to be approved by the FDA hit the shops this week and optimistic dieters are dashing out to buy it.
In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."
Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease.
Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.
› Verified 2 days ago
Kroger Pharmacy #672 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 45 Plaza Dr, Anna, Illinois 62906 Phone: (618) 833-4521 | |
Marion Eye Centers Ltd Type: Durable Medical Equipment & Medical Supplies Supplier Location: 165 Plaza Dr, Anna, Illinois 62906 Phone: (618) 833-8659 | |
Personal Medical Equip * Services I Type: Durable Medical Equipment & Medical Supplies Supplier Location: 517 E Vienna St, Anna, Illinois 62906 Phone: (618) 833-4444 | |
Union County Pharmacy Inc Type: Pharmacy Location: 1785 E Vienna St, Anna, Illinois 62906 Phone: (618) 833-9858 | |
Walgreens #12581 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 745 E Vienna St, Anna, Illinois 62906 Phone: (618) 833-7236 |